Max’s recent stories

By Andriy Rovenchak, Max DruchokOct 02, 2024

Healthcare & Life SciencesR&D

ML Achieves Promising Results in Drug Discovery, Even With Limited Data

Explore machine learning's role in drug discovery in SoftServe’s study.

  10 min read

By Max Druchok, Marta Pinyazhko (Strohush)May 25, 2023

Healthcare & Life SciencesR&D

The Tech (R)evolution in Life Sciences

SoftServe empowers companies to go beyond existing barriers to discover solutions—saving time and money.

  10 min read

By Max Druchok, Oleksandr GurbychMar 23, 2020

R&D

Protein-Peptide Docking

Learn more about our end-to-end molecular docking pipeline that combines deep learning and DFT approaches to predict protein-peptide docking.

  2 min read